AMARIN CORP PLC\UK Income Taxes Paid
AMARIN CORP PLC\UK (AMRN) reported Income Taxes Paid of $3.56 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2026-07-29
- AMARIN CORP PLC\UK income taxes paid, net for the quarter ending 2026-06-30 was $1.23M.
- AMARIN CORP PLC\UK income taxes paid, net for the quarter ending 2026-03-31 was $2.33M, a 10495.45% increase year-over-year.
- AMARIN CORP PLC\UK income taxes paid, net for the quarter ending 2025-12-31 was $1.15M, a 80.95% decline year-over-year.
- AMARIN CORP PLC\UK income taxes paid, net for the quarter ending 2025-09-30 was -$1.00K.
- AMARIN CORP PLC\UK income taxes paid, net for fiscal 2025 was $1.00M, a 74.89% decline from fiscal 2024.
- AMARIN CORP PLC\UK income taxes paid, net for fiscal 2024 was $3.98M, a 68.23% increase from fiscal 2023.
- AMARIN CORP PLC\UK income taxes paid, net for fiscal 2023 was $2.37M.
- AMARIN CORP PLC\UK income taxes paid, net for fiscal 2022 was -$1.78M, a 148.74% decline from fiscal 2021.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 3 month as first filed | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 12 month | Income Taxes Paid, Net 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $3.56M 10-Q · filed 2026-07-29 | $4.71M derived: sum of 3 quarters · filed 2026-07-29 | $4.71M derived: sum of 4 quarters · filed 2026-07-29 | ||
| 2026-03-31 | $2.33M 10-Q · filed 2026-04-29 | $3.48M derived: sum of 2 quarters · filed 2026-04-29 | $3.48M derived: sum of 3 quarters · filed 2026-04-29 | $3.31M derived: sum of 4 quarters · filed 2026-07-29 | ||
| 2025-12-31 | $1.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $1.15M derived: sum of 2 quarters · filed 2026-03-02 | $978.00K derived: sum of 3 quarters · filed 2026-07-29 | $1.00M 10-K · filed 2026-03-02 | ||
| 2025-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | -$170.00K derived: sum of 2 quarters · filed 2026-07-29 | -$148.00K 10-Q · filed 2025-10-29 | $5.88M derived: sum of 4 quarters · filed 2026-07-29 | ||
| 2025-06-30 | -$169.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | -$147.00K 10-Q · filed 2026-07-29 | $5.88M derived: sum of 3 quarters · filed 2026-07-29 | $4.50M derived: sum of 4 quarters · filed 2026-07-29 | ||
| 2025-03-31 | $22.00K 10-Q · filed 2026-04-29 | $6.05M derived: sum of 2 quarters · filed 2026-04-29 | $4.67M derived: sum of 3 quarters · filed 2026-04-29 | $3.98M derived: sum of 4 quarters · filed 2026-04-29 | ||
| 2024-12-31 | $6.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $4.65M derived: sum of 2 quarters · filed 2026-03-02 | $3.95M derived: sum of 3 quarters · filed 2026-03-02 | $3.98M 10-K · filed 2026-03-02 | -$3.98M 10-K · filed 2025-03-12 | |
| 2024-09-30 | -$1.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | -$2.07M derived: sum of 2 quarters · filed 2025-10-29 | -$2.04M 10-Q · filed 2025-10-29 | $1.43M derived: sum of 4 quarters · filed 2026-03-02 | ||
| 2024-06-30 | -$698.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | -$669.00K 10-Q · filed 2025-07-30 | $2.80M derived: sum of 3 quarters · filed 2026-03-02 | $2.37M derived: sum of 4 quarters · filed 2026-03-02 | ||
| 2024-03-31 | $29.00K 10-Q · filed 2025-05-07 | $3.50M derived: sum of 2 quarters · filed 2026-03-02 | $3.07M derived: sum of 3 quarters · filed 2026-03-02 | $2.36M derived: sum of 4 quarters · filed 2026-03-02 | ||
| 2023-12-31 | $3.47M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $3.04M derived: sum of 2 quarters · filed 2026-03-02 | $2.33M derived: sum of 3 quarters · filed 2026-03-02 | $2.37M 10-K · filed 2026-03-02 | -$2.37M 10-K · filed 2024-02-29 | |
| 2023-09-30 | -$432.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | -$1.14M derived: sum of 2 quarters · filed 2024-10-30 | -$1.10M 10-Q · filed 2024-10-30 | -$1.40M derived: sum of 4 quarters · filed 2025-03-12 | ||
| 2023-06-30 | -$709.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | -$671.00K 10-Q · filed 2024-07-31 | -$963.00K derived: sum of 3 quarters · filed 2025-03-12 | -$341.00K derived: sum of 4 quarters · filed 2025-03-12 | ||
| 2023-03-31 | $38.00K 10-Q · filed 2024-05-01 | -$38.00K 10-Q · filed 2023-05-03 | -$254.00K derived: sum of 2 quarters · filed 2025-03-12 | $368.00K derived: sum of 3 quarters · filed 2025-03-12 | -$1.79M derived: sum of 4 quarters · filed 2025-03-12 | |
| 2022-12-31 | -$292.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | $330.00K derived: sum of 2 quarters · filed 2025-03-12 | -$1.83M derived: sum of 3 quarters · filed 2025-03-12 | -$1.78M 10-K · filed 2025-03-12 | ||
| 2022-09-30 | $622.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | -$1.54M derived: sum of 2 quarters · filed 2023-11-01 | -$1.49M 10-Q · filed 2023-11-01 | -$1.50M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-06-30 | -$2.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | -$2.11M 10-Q · filed 2023-08-02 | -$2.13M derived: sum of 3 quarters · filed 2024-02-29 | -$2.17M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-03-31 | $51.00K 10-Q · filed 2023-05-03 | $37.00K derived: sum of 2 quarters · filed 2024-02-29 | -$4.00K derived: sum of 3 quarters · filed 2024-02-29 | $3.70M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2021-12-31 | -$14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$55.00K derived: sum of 2 quarters · filed 2024-02-29 | $3.65M derived: sum of 3 quarters · filed 2024-02-29 | $3.66M 10-K · filed 2024-02-29 | ||
| 2021-09-30 | -$41.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $3.67M derived: sum of 2 quarters · filed 2022-10-27 | $3.67M 10-Q · filed 2022-10-27 | $3.66M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2021-06-30 | $3.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $3.71M 10-Q · filed 2022-08-03 | $3.70M derived: sum of 3 quarters · filed 2023-03-01 | $3.52M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2021-03-31 | $5.00K 10-Q · filed 2022-05-04 | -$5.00K derived: sum of 2 quarters · filed 2023-03-01 | -$182.00K derived: sum of 3 quarters · filed 2023-03-01 | |||
| 2020-12-31 | -$10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$187.00K derived: sum of 2 quarters · filed 2023-03-01 | -$207.00K 10-K · filed 2023-03-01 | |||
| 2020-09-30 | -$177.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | -$197.00K 10-Q · filed 2021-11-03 | ||||
| 2020-06-30 | -$20.00K 10-Q · filed 2021-08-05 | |||||
| 2019-12-31 | -$67.00K 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |